Based on the data available from 2009 to 2015, women diagnosed with localized, regionally extended, and distantly metastasized endometrial carcinoma had a 5-year survival rate of 95%, 69%, and 17%, respectively. For all stages taken together, the overall 5-year survival is around 80%.